期刊
EMBO MOLECULAR MEDICINE
卷 5, 期 4, 页码 483-485出版社
WILEY
DOI: 10.1002/emmm.201302505
关键词
GLI1; NRP2; therapy; triple negative breast tumors; tumor initiating cells
资金
- National Institutes of Health [CA136526, CA165076]
- Mayo Clinic Pancreatic SPORE [P50 CA102701]
- Mayo Clinic Center for Cell Signaling in Gastroenterology [P30 DK84567]
分享论文
